Key facts
- U-Care Medical’s last known valuation is $11.5M (Jan 2025).
- It has raised $1.8M; the latest was Seed Round ($1.1M) in Jan 2025.
- Notable investors include Lazio Innova, Zest Group, Mayo Clinic Platform, Angels for Impact, Bioindustry Park Silvano Fumero — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for U-Care Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for U-Care Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About U-Care Medical
Developer of a cloud-based electronic health record agnostic platform designed to detect and manage critical care complications. The company's platform delivers real-time information about patient kidney health status, entrusts clinicians to reduce the mortality rate in ICU settings, and improves patients' quality of life after hospitalization, enabling doctors to provide real-time prevention and personalized treatment of kidney failures in intensive care units.
- Sector
- Healthcare
- HQ
- Turin, Italy
- Founded
- 2021
- Employees
- 10
- Website
- u-caremedical.com/
- Ownership
- Privately Held (backing)
U-Care Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in U-Care Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on U-Care Medical in its N-PORT filings yet. We sweep new filings monthly.